Home›Companies›Biotech & Pharma›Reservoir Neuroscience

Reservoir Neuroscience, Inc.

Develops treatments intended to heal the blood-brain barrier.

Updated Nov 10, 2026·Latest SEC filing Jun 17, 2026·Suggest an edit

About Reservoir Neuroscience

Reservoir Neuroscience is a private company based in San Francisco, California. It has reported $8,964,994 raised in three offerings on Form D since August 2021. Its chief executive is Aaron Friedman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 8, 2026Jun 17, 2026$2,999,999of $8.0M target2$1.4MEquityRule 506(b)Form D ↗
Nov 14, 2023Nov 22, 2023$2,099,999of $4.0M target7$299KEquityRule 506(b)Form D ↗
Aug 6, 2021Aug 17, 2021$3,864,996of $8.8M target16$241KEquityRule 506(b)Form D ↗
Total, three offerings$8,964,994

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Reservoir Neuroscience's Form D filed Jun 17, 2026.

Earlier filings also listed Patrick Burgermeister (director, last listed Nov 2023) and Tracy Saxton (director, last listed Aug 2021).

Sources

  1. SECReservoir Neuroscience, Inc. filing history
  2. CompanyContact